220. Allison Wagner and Dr. Matthew Fedoruk | U.S. Anti-Doping Agency

220. Allison Wagner and Dr. Matthew Fedoruk | U.S. Anti-Doping Agency

High Truths on Drugs and Addiction

Dr. Matthew Fedoruk currently works as the Chief Science Officer leading the Science & Research team at the U.S. Anti-Doping Agency (USADA). Dr. Fedoruk is considered an expert in the scientific aspects of anti-doping matters and has reviewed hundreds of results management cases while at USADA and provided credible scientific guidance and opinion to resolve many anti-doping analytical and non-analytical result management cases including the detection of performance-enhancing drugs and the abuse thereof in sport. With more than 10 years of experience in anti-doping and a Ph.D. in Pathology and Laboratory Medicine, Dr. Fedoruk also serves as a standing member of the IPC Anti-Doping Committee, the WADA TDSSA Expert Group Chair and Athlete Biological Passport (ABP) Ad-Hoc Working Group. Dr. Fedoruk also serves as co-Chair of the Scientific Advisory Board for the Partnership for Clean Competition (PCC). Before joining USADA, Dr. Fedoruk worked at the Canadian Centre for Ethics in Sport (CCES) and served with the Vancouver 2010 Organizing Committee for the 2010 Olympic and Paralympic Winter Games in Canada. He currently lives in sunny Colorado Springs, Colorado, which is also known as ‘Olympic Town USA’ for being home to the U.S. Olympic Committee, the high-altitude Olympic Training Center, numerous national sport federations and USADA. Allison Wagner The U.S. Anti-Doping Agency (USADA) is pleased to announce that it has welcomed Allison Wagner, a silver medalist swimmer at the 1996 Olympic Games in Atlanta, as its first Director of Athlete and International Relations. In this role, Wagner will oversee Olympic, Paralympic, Pan American, and Parapan American athlete engagement efforts that will help USADA serve athletes and best meet their needs. Wagner will also work to ensure effective relationships with key international partners and advocate for anti-doping excellence on a global scale. In addition to her experience as an elite swimmer, Allison brings to this role her recent experience as a research associate at the Sports Equity Lab at Yale University and as a postgraduate student in the Erasmus Mundus Program, a joint master’s degree delivered by an international consortium of six higher education institutions in the European Union. Wagner is one of six Olympians worldwide to be selected by the International Olympic Committee for this program – a world-first innovation developed by the European Commission as a response to the global challenge to sport integrity. These programs allowed her to lead athlete outreach initiatives and develop expertise in international relations and sport governance, anti-doping policy, abuse and discrimination, athletes’ rights and advocacy, diversity and inclusion, and disability in sport. With this knowledge, she developed concrete and practical solutions related to policy, governance, and communication. “Allison is passionate about athletes’ rights and standing up for them,” said USADA CEO Travis T. Tygart. “As an Olympian and scholar, through engagement with our athletes and international partners, Allison will elevate our mission to serve athletes and ensure that their rights are protected around the world.” Wagner also has first-hand experience with one of the key reasons that a strong global anti-doping system is so important: She was beaten in major championships by swimmers who were later proven to be users of banned performance-enhancing substances. Despite these challenges, Wagner enjoyed a decorated swimming career, including holding a world record in the 200 I.M. (SCM) for almost 15 years, seven Southeastern Conference titles, 11 All-American honors, recognition as the SEC Female Swimmer of the Year in 1995 and 1996, and the University of Florida’s Most Valuable Swimmer in 1996. She earned the silver medal in the 400-meter...